sacituzumab govitecan for patients with advanced urothelial carcinoma
Published 2 years ago • 7 plays • Length 4:54Download video MP4
Download video MP3
Similar videos
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
6:01
sacituzumab govitecan given accelerated fda approval for advanced urothelial cancer
-
1:18
dr. tagawa on next steps with sacituzumab govitecan in advanced urothelial carcinoma
-
0:40
neoadjuvant sacituzumab govitecan for muscle-invasive bladder cancer
-
3:39
sacituzumab govitecan in previously treated metastatic urothelial carcinoma
-
2:09
petros grivas on the efficacy of sacituzumab govitecan for bladder cancer
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
2:49
enfortumab vedotin vs chemotherapy for advanced urothelial carcinoma
-
1:10
use of sacituzumab govitecan in metastatic urothelial carcinoma
-
4:04
efficacy of sacituzumab govitecan by trop-2 expression in metastatic urothelial carcinoma
-
1:38
dr. tagawa on sacituzumab govitecan in urothelial carcinoma
-
4:34
neoadjuvant sacituzumab govitecan showed promising activity in muscle-invasive urothelial bladde...
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
4:21
sacituzumab govitecan plus enfortumab vedotin for treatment of advanced urothelial cancer
-
3:54
biomarker analysis: sacituzumab govitecan vs chemotherapy in metastatic tpn breast cancer
-
1:11
using sacituzumab govitecan and other adcs in urothelial cancers
-
0:52
dad trial: combining sacituzumab govitecan and ev for the treatment of bladder cancer
-
2:50
new data on antibody-drug conjugates & novel compounds for 2nd-line urothelial carcinoma treatment